| P50 | author | Ronald Blanton | Q42855342 |
| | Benigno Rodriguez | Q42870636 |
| P2093 | author name string | Clifford V Harding | |
| | Donald D Anthony | |
| | Nicole L Yonkers | |
| | Gareth Hardy | |
| | Yngve Falck-Ytter | |
| | Sara J Conry | |
| | Julia M Sugalski | |
| | Perica Davitkov | |
| | Qinglai Meng | |
| | Amy Hirsch | |
| | Anita Compan | |
| P2860 | cites work | In vivo significance of NK cell on resistance against virus (HSV-1) infections in mice | Q45804239 |
| | Functionally relevant decreases in activatory receptor expression on NK cells are associated with pulmonary tuberculosis in vivo and persist after successful treatment. | Q47747530 |
| | Interferon-alfa, interferon-lambda and hepatitis C. | Q50561807 |
| | Expansion of CD56- NK cells in chronic HCV/HIV-1 co-infection: reversion by antiviral treatment with pegylated IFNalpha and ribavirin. | Q50568553 |
| | Severe herpesvirus infections in an adolescent without natural killer cells | Q55984308 |
| | APRI: an easy and validated predictor of hepatic fibrosis in chronic hepatitis C | Q79852758 |
| | Decreased NK cell frequency in chronic hepatitis C does not affect ex vivo cytolytic killing | Q82639999 |
| | Differential Effects of Hepatitis C Virus JFH1 on Human Myeloid and Plasmacytoid Dendritic Cells | Q27488392 |
| | Effect of Killer Immunoglobulin-Like Receptors in the Response to Combined Treatment in Patients with Chronic Hepatitis C Virus Infection | Q27490541 |
| | Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection | Q27860901 |
| | Hepatitis C virus infection | Q27861002 |
| | Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance | Q28255243 |
| | Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines | Q28260203 |
| | Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients | Q28274666 |
| | Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons | Q28274676 |
| | Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus | Q28279955 |
| | Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial | Q28298301 |
| | IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy | Q29614896 |
| | Estimating African American admixture proportions by use of population-specific alleles | Q29616216 |
| | Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C | Q29619541 |
| | Pharmacodynamics of PEG-IFN-alpha-2a in HIV/HCV co-infected patients: implications for treatment outcomes | Q34208650 |
| | Estimating progression to cirrhosis in chronic hepatitis C virus infection. | Q34389608 |
| | The developmental relationship between NK cells and T cells | Q35451601 |
| | Early changes in natural killer cell function indicate virologic response to interferon therapy for hepatitis C. | Q35964254 |
| | IL28B and the Control of Hepatitis C Virus Infection | Q37800518 |
| | Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection. | Q39723501 |
| | Histone deacetylase inhibitors suppress natural killer cell cytolytic activity | Q40161252 |
| | NK sensitivity of neuroblastoma cells determined by a highly sensitive coupled luminescent method | Q40349680 |
| | Ontogeny, specific functions and receptors of human natural killer cells | Q40705353 |
| | Brief report: killer cell defect and persistent immunological abnormalities in two patients with chronic active Epstein-Barr virus infection | Q40774717 |
| | Immunological alterations associated with recurrent herpes simplex genitalis | Q41888487 |
| | Impaired plasmacytoid dendritic cell (PDC)-NK cell activity in viremic human immunodeficiency virus infection attributable to impairments in both PDC and NK cell function | Q42614451 |
| | Accumulation of natural killer and cytotoxic T large granular lymphocytes in the liver during virus infection | Q42938534 |
| | HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection | Q42986755 |
| | Pharmacogenomics. Gene variants affect hepatitis C treatment, but link is elusive | Q43001077 |
| | Activating NK cell receptor expression/function (NKp30, NKp46, DNAM-1) during chronic viraemic HCV infection is associated with the outcome of combined treatment | Q43037932 |
| | Expansion of functionally skewed CD56-negative NK cells in chronic hepatitis C virus infection: correlation with outcome of pegylated IFN-alpha and ribavirin treatment | Q44873615 |
| | Altered interferon-alpha-signaling in natural killer cells from patients with chronic hepatitis C virus infection | Q45375236 |
| | Immunological studies of herpes simplex virus infection in children with atopic eczema | Q45769131 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Hepatitis C virus | Q708693 |
| P304 | page(s) | 1131-1141 | |
| P577 | publication date | 2012-02-20 | |
| P1433 | published in | Journal of Infectious Diseases | Q4051141 |
| P1476 | title | Genetically associated CD16(+)56(-) natural killer cell interferon (IFN)-αR expression regulates signaling and is implicated in IFN-α-induced hepatitis C virus decline | |
| P478 | volume | 205 | |